Prenetics Global (PRENW) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.01, -29.20% vs the prior close of $0.01.
- Volume 26.27K shares, 5.9x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)
PRENW slides 29.2% to $0.01 on 5.9x normal volume. Closed at $0.01, -29.20% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.02.
PRENW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — PRENW slides 29.2% to $0.01 on 5.9x normal volume
- Closed at $0.01, -29.20% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.02.
- Volume was 26.27K shares, 5.9x its 50-day average of 4.45K — unusually heavy trading.
- 52-week range $0.01–$0.01; today's close sits at 6% of that range, 29.2% below the 52-week high.
PRENW bull case vs bear case (from the data)
- Insiders made 20 open-market purchases in the last 12 months.
- High volatility: average daily move of 29.2% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
PRENW latest news & SEC filings
Every SEC filing by or about PRENW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leogrande Hudson Blake converted options/RSUs into 2,000 shares on Oct 4, 2026; now holds 8,001
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lo Hoi Chun converted options/RSUs into 7,635 shares on Sep 30, 2026; now holds 573,648
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 5,100 shares at $22.80 (≈$116.28K) on Aug 25, 2026
- Rosin Brian J bought 18,000 shares at $21.19 (≈$381.42K) on Aug 24, 2026
- Rosin Brian J bought 18,000 shares at $21.19 (≈$381.42K) on Aug 24, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 21, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade PRENW
- How much it moves: over the last 20 sessions the average daily move was 29.20% (largest 29.2%). That is a volatile stock.
- Liquidity: about 15.36K shares (≈$123) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.01 vs a range of $0.01–$0.01 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Brian J Rosin bought 5,100 shares on Aug 25, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Aug 26, 2026; 6-K Aug 20, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PRENW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.02 | 0.01 | 0.01 | 0.01 | 26.27K |
| Oct 16, 2026 | 0.02 | 0.01 | 0.01 | 0.01 | 4.45K |
About Prenetics Global
Prenetics Global (PRENW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in QUARRY BAY, Hong Kong. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1876431.
PRENW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Yin Pan Cheng | Wholly owned by Cheng Yin Pan | Jun 16, 2026 |
| Hudson Blake Leogrande | Director | Sep 4, 2026 |
| Caroline S Levy | Director | Aug 26, 2026 |
| Darshan Ravindra Shah | Director | Mar 30, 2026 |
| David Vanderveen | Director | Jun 16, 2026 |
| Danny Sheng Wu Yeung | Chief Executive Officer | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hoi Chun Lo | Chief Financial Officer | Aug 24, 2026 |
| Brian J Rosin | CFO of IM8 (US) LLC | Aug 26, 2026 |
| Thuan Yen Tat | VP, Finance of IM8 (US) LLC | Sep 4, 2026 |
| Danny Sheng Wu Yeung | Chief Executive Officer | Aug 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 25, 2026 | Brian J Rosin | Buy | 5,100 | $22.80 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Brian J Rosin | Buy | 18,000 | $21.19 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 6,000 | $20.90 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 6,000 | $20.90 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 6,000 | $20.90 |
| Aug 24, 2026 | Danny Sheng Wu Yeung | Buy | 11,181 | $21.40 |
PRENW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PRENW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on PRENW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.